Nutrition Support in Children with Severe Pneumonia - Trial PACTR202106635355751
Access comprehensive clinical trial information for PACTR202106635355751 through Pure Global AI's free database. This Phase 2 trial is sponsored by Imperial College London and is currently Recruiting. The study focuses on Respiratory; Paediatrics.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Imperial College London
European and Developing Countries Clinical Trials Partnership
Timeline & Enrollment
Phase 2
Aug 10, 2018
Jan 01, 1900
Summary
Worldwide, pneumonia is a major cause of death in children both during initial hospital admission and in the 6 months following discharge. The major risk factor for longterm mortality this is poor nutritional status. Currently no nutritional support is recommended for children without severe malnutrition. The COAST examines treatment recommendations regarding which children should receive oxygen. At 48 hours we then enrolled children into a nutrition trial: COAST Nutrition. This trial is examining whether supplementing the usual diet with a Ready-to-Use Therapeutic feed (usually given to children with severe malnutrition) for the following 56 days improves their outcomes (measured by better growth in terms of the fatness of their arms, called mid-upper arm circumference, and whether this improves survival 6months after their initial hospital admission.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202106635355751
Non-Device Trial